Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'superficial bladder cancer' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 251 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Saint, F; Patard, JJ; Muscatelli, BG; Belda, MAL; de Medina, SGD; Abbou, CC; Chopin, DK
      Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment

      BJU INTERNATIONAL
    2. Billerey, C; Sibony, M; Chopin, D; Gattegno, B
      Pathology

      PROGRES EN UROLOGIE
    3. Gattegno, B; Chopin, D
      Natural history

      PROGRES EN UROLOGIE
    4. Gattegno, B; Chopin, D
      Local staging

      PROGRES EN UROLOGIE
    5. Chopin, D; Gattegno, B
      Intravesical chemotherapy

      PROGRES EN UROLOGIE
    6. Chopin, D; Saint, F; Gattegno, B
      Intravesical immunotherapy/bacille Calmette-Guerin

      PROGRES EN UROLOGIE
    7. Gattegno, B; Chopin, D
      Photodynamic therapy

      PROGRES EN UROLOGIE
    8. Gattegno, B; Chopin, D
      Cystectomy

      PROGRES EN UROLOGIE
    9. Gattegno, B; Chopin, D
      Surveillance

      PROGRES EN UROLOGIE
    10. Saint, F; Irani, J; Salomon, L; Debois, H; Abbou, CC; Chopin, D
      Study of the safety and efficacy of maintenance treatment with intravesical BCG instillation in the prevention of superficial bladder tumours.

      PROGRES EN UROLOGIE
    11. Lachand, AT; Texier, J; Texier, P
      Surveillance and prognosis of stage Ta superficial bladder cancers. A homogeneous series of 138 cases followed for 1 to 18 years

      PROGRES EN UROLOGIE
    12. Lachand, AT; Texier, J; Texier, P
      Surveillance and prognosis of stage T1 superficial bladder tumours. A homogeneous series of 89 cases followed for 1 to 22 years.

      PROGRES EN UROLOGIE
    13. Cohen, PA; Peng, LM; Kjaergaard, J; Plautz, GE; Finke, JH; Koski, GK; Czerniecki, BJ; Shu, SY
      T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance

      CRITICAL REVIEWS IN IMMUNOLOGY
    14. Shoenfeld, Y; Aron-Maor, A; Tanai, A; Ehrenfeld, M
      BCG and autoimmunity: Another two-edged sword

      JOURNAL OF AUTOIMMUNITY
    15. Poon, RTP; Fan, ST; Wong, J
      Clinical implications of circulating angiogenic factors in cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    16. Legout, L; Maulin, L; Senneville, E; Leduc, L; Leroy, O; Georges, H; Guery, B; Beaucaire, G; Mouton, Y
      Mycobacterial sepsis following instillation of intravesical Calmette-Guerin bacillus. Is corticosteroidal therapy necessary?

      MEDECINE ET MALADIES INFECTIEUSES
    17. Bradner, WT
      Mitomycin C: a clinical update

      CANCER TREATMENT REVIEWS
    18. Raitanen, MP; Hellstrom, P; Marttila, T; Korhonen, H; Talja, M; Ervasti, J; Tammela, TLJ
      Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test

      EUROPEAN UROLOGY
    19. Newling, DWW; Hetherington, J; Sundaram, SK; Robinson, MRG; Kisbenedek, L
      The use of valrubicin for the chemoresection of superficial bladder cancer- A marker lesion study

      EUROPEAN UROLOGY
    20. Brandau, S; Bohle, A
      Activation of natural killer cells by bacillus Calmette-Guerin

      EUROPEAN UROLOGY
    21. Kamphuis, JT; Buiting, AGM; Misere, JFMM; Henegouwen, DPV; van Soolingen, D; Rensma, PL
      BCG immunotherapy: be cautious of granulomas - Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations

      NETHERLANDS JOURNAL OF MEDICINE
    22. Loertzer, H; Brake, M; Horsch, R; Keller, H
      Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical bacillus Calmette-Guerin therapy?

      UROLOGY
    23. Ackroyd, R; Kelty, C; Brown, N; Reed, M
      The history of photodetection and photodynamic therapy

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    24. Korbelik, M; Sun, JH; Posakony, JJ
      Interaction between photodynamic therapy and BCG immunotherapy responsiblefor the reduced recurrence of treated mouse tumors

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    25. Geldmacher, H; Taube, C; Markert, U; Kirsten, DK
      Nearly fatal complications of cervical lymphadenitis following BCG immunotherapy for superficial bladder cancer

      RESPIRATION
    26. Dutta, SC; Smith, JA; Shappell, SB; Coffey, CS; Chang, SS; Cookson, MS
      Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy

      JOURNAL OF UROLOGY
    27. Lamm, DL
      Stage progression in TA papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy - Editorial comment

      JOURNAL OF UROLOGY
    28. Konety, BR; Getzenberg, RH
      Urine based markers of urological malignancy

      JOURNAL OF UROLOGY
    29. Luo, Y; Chen, X; Han, R; O'Donnell, MA
      Recombinant bacille Calmette-Guerin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    30. Raitanen, MP; Kaasinen, E; Rintala, E; Hansson, E; Nieminen, P; Aine, R; Tammela, TJ
      Prognostic utility of human complement factor H related protein test (the BTA stat (R) Test)

      BRITISH JOURNAL OF CANCER
    31. Engelhardt, PF; Simak, R; Daha, LK; Plas, E; Pfluger, H
      Ranking of the 2nd-look transurethral electroresection of the superficial carcinoma of the bladder

      AKTUELLE UROLOGIE
    32. Loertzer, H; Brake, M; Horsch, R; Keller, H
      Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical BCG therapy?

      AKTUELLE UROLOGIE
    33. Au, JLS; Badalament, RA; Wientjes, MG; Young, DC; Warner, JA; Venema, PL; Pollifrone, DL; Harbrecht, JD; Chin, JL; Lerner, SP; Miles, BJ
      Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    34. Au, JLS; Wientjes, MG
      Re: Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial - Response

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    35. Sokolova, IA; Halling, KC; Jenkins, RB; Burkhardt, HM; Meyer, RG; Seelig, SA; King, W
      The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine

      JOURNAL OF MOLECULAR DIAGNOSTICS
    36. Li, Q; Normolle, DP; Sayre, DM; Zeng, XY; Sun, R; Jiang, GH; Redman, B; Chang, AE
      Immunological effects of BCG as an adjuvant in autologous tumor vaccines

      CLINICAL IMMUNOLOGY
    37. Yamamoto, Y; Nasu, Y; Saika, T; Akaeda, T; Tsushima, T; Kumon, H
      The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer

      BJU INTERNATIONAL
    38. Cliff, AM; Heatherwick, B; Scoble, J; Parr, NJ
      The effect of fasting or desmopressin before treatment on the concentration of mitomycin C during intravesical administration

      BJU INTERNATIONAL
    39. Desgrippes, A; Izadifar, V; Assailly, J; Fontaine, E; Beurton, D
      Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology

      BJU INTERNATIONAL
    40. Tosoni, I; Wagner, U; Sauter, G; Egloff, M; Knonagel, H; Alund, G; Bannwart, F; Mihatsch, MJ; Gasser, TC; Maurer, R
      Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

      BJU INTERNATIONAL
    41. Raghunand, N; Gillies, RJ
      pH and drug resistance in tumors

      DRUG RESISTANCE UPDATES
    42. Saint, F; Patard, JJ; Salomon, L; Alame, W; Cicco, A; Abbou, CC; Chopin, D
      Mechanisms of action of BCG: towards an individualized therapeutic approach?

      PROGRES EN UROLOGIE
    43. Champetier, D; Valignat, C; Lopez, JG; Ruffion, A; Devonec, M; Perrin, P
      Intravesical BCG-therapy: comparison of the adverse effects of Connaught (Toronto) and Pasteur (Paris) strains.

      PROGRES EN UROLOGIE
    44. Darieva, ZA; Lasunskaia, EB; Kipnis, TL; Da Silva, WD
      Two BCG vaccine formulations prepared from the same strain with different J774 macrophage activation capacities and patterns of NF-kappa B induction

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    45. Begleiter, A
      Clinical applications of quinone-containing alkylating agents

      FRONTIERS IN BIOSCIENCE
    46. Brandau, S; Suttmann, H; Riemensberger, J; Seitzer, U; Arnold, J; Durek, C; Jocham, D; Flad, HD; Bohle, A
      Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guerin-activated killer cells

      CLINICAL CANCER RESEARCH
    47. Menke, JJ; Heins, JR
      Epididymo-orchitis following intravesical bacillus Calmette-Guerin therapy

      ANNALS OF PHARMACOTHERAPY
    48. Brandau, S; Bohle, A; Thanhauser, A; Ernst, M; Mattern, T; Ulmer, AJ; Flad, HD
      In vitro generation of bacillus Calmette-Guerin-activated killer cells

      CLINICAL INFECTIOUS DISEASES
    49. Bohle, A; Thanhauser, A; Ernst, M; Flad, HD; Rusch-Gerdes, S; Jocham, D; Ulmer, AJ
      Reduction of side effects of intravesical therapy with bacille Calmette-Guerin by pentoxifylline? An in vitro approach

      CLINICAL INFECTIOUS DISEASES
    50. Borden, EC; Lindner, D; Dreicer, R; Hussein, M; Peereboom, D
      Second-generation interferons for cancer: clinical targets

      SEMINARS IN CANCER BIOLOGY
    51. Kakizoe, T
      Asian studies of cancer chemoprevention: latest clinical results

      EUROPEAN JOURNAL OF CANCER
    52. Bilen, CY; Ozen, H; Aki, FT; Aygun, CEM; Ekici, S; Kendi, S
      Clinical experience with BCG alone versus BCG plus epirubicin

      INTERNATIONAL JOURNAL OF UROLOGY
    53. Nagao, F; Nakayama, M; Muto, T; Okumura, K
      Effects. of a fennented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    54. Gottke, MU; Wong, P; Muhn, C; Jabbari, M; Morin, S
      Hepatitis in disseminated bacillus Calmette-Guerin infection

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    55. Lebret, T; Becette, V; Herve, JM; Molinie, V; Barre, P; Lugagne, PM; Gentille, A; Baglin, AC; Botto, H
      Prognostic value of MIB-1 antibody labeling index to predict response to bacillus Calmette-Guerin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer

      EUROPEAN UROLOGY
    56. Zlotta, AR; Van Vooren, JP; Huygen, K; Drowart, A; Decock, M; Pirson, M; Jurion, F; Palfliet, K; Denis, O; Simon, J; Schulman, CC
      What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

      EUROPEAN UROLOGY
    57. Oge, O; Erdem, E; Atsu, N; Sahin, A; Ozen, H
      Proposal for changes in cystoscopic follow-up of patients with low-grade pTa gladder tumor

      EUROPEAN UROLOGY
    58. Bohle, A
      BCG's mechanism of action - Increasing our understanding

      EUROPEAN UROLOGY
    59. Lamm, DL
      Preventing progression and improving survival with BCG maintenance

      EUROPEAN UROLOGY
    60. Malmstrom, PU
      Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience

      EUROPEAN UROLOGY
    61. Durek, C; Rusch-Gerdes, S; Jocham, D; Bohle, A
      Sensitivity of BCG to modern antibiotics

      EUROPEAN UROLOGY
    62. Bassi, P; Spinadin, R; Carando, R; Balta, G; Pagano, F
      Modified induction course: A solution to side-effects?

      EUROPEAN UROLOGY
    63. Liukkonen, T; Lipponen, P; Raitanen, M; Kaasinen, E; Ala-Opas, M; Rajala, P; Kosma, VM
      Evaluation of p21(WAF1/CIP1) and cyclin D-1 expression in the progression of superficial bladder cancer

      UROLOGICAL RESEARCH
    64. Saarela, M; Mogensen, G; Fonden, R; Matto, J; Mattila-Sandholm, T
      Probiotic bacteria: safety, functional and technological properties

      JOURNAL OF BIOTECHNOLOGY
    65. Luo, Y; Chen, XH; Szilvasi, A; O'Donnell, MA
      Co-expression of interleukin-2 and green fluorescent protein reporter in mycobacteria: in vivo application for monitoring antimycobacterial immunity

      MOLECULAR IMMUNOLOGY
    66. Jabbour, ME; Smith, AD
      Primary percutaneous approach to upper urinary tract transitional cell carcinoma

      UROLOGIC CLINICS OF NORTH AMERICA
    67. Roehrborn, CG; Dolte, KS; Ross, KS; Girman, CJ
      Incidence and risk reduction of long-term outcomes: A comparison of benignprostatic hyperplasia with several other disease areas

      UROLOGY
    68. Leung, NJ; Aldovini, A; Young, R; Jarvis, MA; Smith, JM; Meyer, D; Anderson, DE; Carlos, MP; Gardner, MB; Torres, JV
      The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins

      VIROLOGY
    69. Danisman, A; Bulut, K; Kukul, E; Ozen, I; Sevuk, M
      Urinary fibronectin levels in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer

      UROLOGIA INTERNATIONALIS
    70. Takashi, M; Schenck, U; Koshikawa, T; Nakashima, N; Ohshima, S
      Cytological changes induced by intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

      UROLOGIA INTERNATIONALIS
    71. Wijkstrom, H; Cohen, SM; Gardiner, RA; Kakizoe, T; Schoenberg, M; Steineck, G; Tobisu, K
      Prevention and treatment of urothelial premalignant and malignant lesions

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    72. Popken, G; Schultze-Seemann, W; Seiler, KU; Birkel, M; Wetterauer, U
      Intravesical administration of 5-aminolevulinic acid (5-ALA) - Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    73. Halling, KC; King, W; Sokolova, IA; Meyer, RG; Burkhardt, HM; Halling, AC; Cheville, JC; Sebo, TJ; Ramakumar, S; Stewart, CS; Pankratz, S; O'Kane, DJ; Seelig, SA; Lieber, MM; Jenkins, RB
      A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

      JOURNAL OF UROLOGY
    74. Pavlovich, CP; Kraling, BM; Stewart, RJ; Chen, XH; Bochner, BH; Luster, AD; Poppas, DP; O'Donnell, MA
      BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation

      JOURNAL OF UROLOGY
    75. Zhang, GJ; Crist, SA; McKerrow, AK; Xu, Y; Ladehoff, DC; See, WA
      Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha 5 beta 1 fibronectin receptor

      JOURNAL OF UROLOGY
    76. Kondylis, FI; Demirci, S; Ladaga, L; Kolm, P; Schellhammer, PF
      Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transition cell carcinoma

      JOURNAL OF UROLOGY
    77. Kaasinen, ES; Harju, LM; Alfthan, OS; Timonen, TT
      Non-specific, rapidly generated cytotoxicity in lymphocytes induced by BCGin vitro: No evidence of enhancing effect from preceding interaction between BCG and transitional cell line cells

      JOURNAL OF UROLOGY
    78. Zhao, WC; Schorey, JS; Bong-Mastek, M; Ritchey, J; Brown, EJ; Ratliff, TL
      Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity

      INTERNATIONAL JOURNAL OF CANCER
    79. Koenig, F; Jung, K; Schnorr, D; Loening, SA
      Urinary markers of malignancy

      CLINICA CHIMICA ACTA
    80. Murphy, WM
      Clarity in the clinical medical literature - We are no longer preaching tothe choir

      CANCER CYTOPATHOLOGY
    81. Ross, JS; Cohen, MB
      Ancillary methods for the detection of recurrent urothelial neoplasia

      CANCER CYTOPATHOLOGY
    82. Cheng, L; Neumann, RM; Nehra, A; Spotts, BE; Weaver, AL; Bostwick, DG
      Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma

      CANCER
    83. de Roos, NM; Katan, MB
      Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    84. Jocham, D; Gaertner, T
      Photodynamic diagnosis and therapy in urology

      AKTUELLE UROLOGIE
    85. Molto, L; Carballido, J; Manzano, L; Martinez-Martin, B; Esquivel, F; Chafer, J; Olivier, C; Alvarez-Mon, M
      Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2

      JOURNAL OF IMMUNOTHERAPY
    86. Bartlett, JMS; Adie, L; Watters, AD; Going, JJ; Grigor, KM
      Chromosomal aberrations in transitional cell carcinoma that are predictiveof disease outcome are independent of polyploidy

      BJU INTERNATIONAL
    87. Doherty, AP; Trendell-Smith, N; Stirling, R; Rogers, H; Bellringer, J
      Perivesical fat necrosis after adjuvant intravesical chemotherapy

      BJU INTERNATIONAL
    88. Famularo, G; De Simone, C; Matteuzi, D; Pirovano, F
      Traditional and high potency probiotic preparations for oral bacteriotherapy

      BIODRUGS
    89. Cozzi, PJ; Bajorin, DF; Tong, W; Nguyen, H; Scott, J; Heston, WDW; Dalbagni, G
      Toxicology and pharmacokinetics of intravesical gemcitabine: A preclinicalstudy in dogs

      CLINICAL CANCER RESEARCH
    90. Naidu, AS; Bidlack, WR; Clemens, RA
      Probiotic spectra of lactic acid bacteria (LAB)

      CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
    91. Mattila-Sandholm, T; Matta, J; Saarela, M
      Lactic acid bacteria with health claims - interactions and interference with gastrointestinal flora

      INTERNATIONAL DAIRY JOURNAL
    92. Ouwehand, AC; Kirjavainen, PV; Shortt, C; Salminen, S
      Probiotics: mechanisms and established effects

      INTERNATIONAL DAIRY JOURNAL
    93. Kondo, T; Onitsuka, S; Ryoji, O; Kihara, T; Goto, Y; Satoh, T; Nakazawa, H; Toma, H
      Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesical epirubicin therapy

      INTERNATIONAL JOURNAL OF UROLOGY
    94. Yaman, O; Ozdiler, E; Sozen, S; Gogus, O
      Transmurally absorbed intravesical chemotherapy with dimethylsulfoxide in an animal model

      INTERNATIONAL JOURNAL OF UROLOGY
    95. Schwartzenberg, JM; Smith, DD; Lindsley, HB
      Bacillus Calmette-Guerin associated arthropathy mimicking undifferentiatedspondyloarthropathy

      JOURNAL OF RHEUMATOLOGY
    96. Highley, MS; van Oosterom, AT; Maes, RA; De Bruijn, EA
      Intravesical drug delivery - Pharmacokinetic and clinical considerations

      CLINICAL PHARMACOKINETICS
    97. Cope, NJ; McCullagh, P; Sarsfield, PTL
      Tumour responding accessory cells in testicular seminoma: an immunohistochemical study

      HISTOPATHOLOGY
    98. Liukkonen, T; Rajala, P; Raitanen, M; Rintala, E; Kaasinen, E; Lipponen, P
      Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: A prospective comparative study

      EUROPEAN UROLOGY
    99. Jennings, AM; Solomon, LZ; Sharpe, P; Hayes, MC; Cooper, AJ; Birch, BR
      Estramustine reversal of resistance to intravesical epirubicin chemotherapy

      EUROPEAN UROLOGY
    100. Laaksovirta, S; Rajala, P; Nurmi, M; Tammela, TLJ; Laato, M
      The cytostatic effect of 9-cis-retinoic acid, tretinoin, and isotretinoin on three different human bladder cancer cell lines in vitro

      UROLOGICAL RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:42:10